Sturm, Ruger & Company, Inc. — Q3 2023 Form 10-Q
Reporting period: Three and nine months ended September 30, 2023; comparisons are with the three and nine months ended October 1, 2022. Dollars are in millions unless otherwise noted. The company designs, manufactures, and sells firearms, primarily in the U.S.; firearms account for about 99% of sales. Castings account for less than 1%.
Key financial results
| Metric | Q3 2023 | Q3 2022 | Nine months 2023 | Nine months 2022 |
|---|---|---|---|---|
| Net sales | $120.9 | $139.4 | $413.2 | $446.6 |
| Gross profit / margin | $24.7 / 20.5% | $38.9 / 27.9% | $101.4 / 24.5% | $140.5 / 31.5% |
| Operating income | $6.3 | $19.9 | $41.8 | $83.8 |
| Net income | $7.4 | $18.4 | $38.0 | $69.4 |
| Diluted EPS | $0.42 | $1.03 | $2.13 | $3.90 |
| Operating cash flow | Not provided for quarter | Not provided for quarter | $17.3 | $50.3 |
| EBITDA / EBITDA margin (non-GAAP) | $13.3 / 11.0% | $27.0 / 19.4% | $62.4 / 15.1% | $106.0 / 23.7% |
Financial position and cash flow
- At September 30, cash was $13.6 and short-term investments were $106.5, totaling $120.0. Working capital was $212.8 after the LIFO reserve; the current ratio was 4.5 to 1.
- The company had no borrowings under its $40 million unsecured revolving credit facility, which expires January 7, 2025, and reported compliance with its covenants. Lease liabilities totaled $2.9. No other debt balance is reported in the filing text.
- Nine-month operating cash flow fell to $17.3 from $50.3. Capital expenditures were $11.6, versus $17.2 a year earlier. Cash used for dividends was $107.8, including an $88.3 million payment of the $5.00-per-share special dividend declared in 2022.
- Cash declined by $51.6 during the nine months to $13.6. Investing activities provided $41.0, primarily reflecting net maturities of short-term investments; financing activities used $110.0.
Material changes and operating trends
- Q3 sales decreased 13.3% year over year and nine-month sales decreased 7.5%. Firearms sales accounted for nearly all of the decline; castings sales were small.
- Management attributed weaker sales to softer consumer demand. Estimated distributor-to-retailer sell-through fell 8% in the first nine months, while adjusted NICS background checks fell 7%.
- Gross margin contracted by 7.4 percentage points in Q3 and 7.0 points for the nine-month period. Management cited lower sales and production, fixed-cost deleveraging, promotional costs, inflation in materials and other costs, and a mix shift toward lower-margin products; pricing increases partly offset these pressures.
- Production decreased 18% in the first nine months. At quarter-end, company inventory was 176,100 units and distributor inventory was 306,200 units; both were higher than at the start of 2023. The ending unit backlog was 460,000, down from 884,400 a year earlier.
- New products represented $27.2 million, or 22.9%, of Q3 firearm sales and $90.5 million, or 22.7%, of nine-month firearm sales.
- Lower nine-month earnings also reflected operating expenses up 5.0% year over year. Interest income increased, while the nine-month effective tax rate declined to 18.9% from 19.9%, principally due to higher-than-anticipated tax credits identified upon filing 2022 returns.
Outlook, risks, and unusual items
- No specific sales or earnings guidance is provided. Management expects approximately $20 million of 2023 capital expenditures for new product introductions and manufacturing equipment and facilities, while noting actual spending could vary significantly.
- The company’s dividend policy is to pay approximately 40% of net income, with the quarterly amount varying with earnings. After quarter-end, the board authorized a $0.17-per-share dividend, payable November 29, 2023. Future dividends depend on performance, available cash and investments, and funding needs.
- Management highlighted risks from changing firearm demand, raw-material availability and inflation, production disruption, litigation, and future firearms-control or environmental regulation. It also noted reliance on a limited number of independent distributors and significant self-insurance and policy deductibles.
- At September 30, the company was a defendant in eight lawsuits and was aware of other claims, including municipal litigation, negligence claims, and cases related to alleged unfair trade practices. Management said a material adverse effect on financial position was not probable, but litigation could materially affect results in a particular period. It could not estimate a range of reasonably possible losses; certain municipal claims are excluded from specified insurance coverage.
- The company reported no material change in risk factors, no material adverse business impact from COVID-19 during the period, and effective disclosure controls. A Rule 10b5-1 plan for an officer covering potential sales of up to 2,919 shares was disclosed after an administrative omission in the prior quarterly filing.
Important facts for investors to verify
- Whether distributor and retailer demand stabilizes, and whether company and distributor inventories continue to rise or begin to normalize.
- Whether pricing, product mix, production levels, and cost inflation improve gross margins and operating cash flow.
- Whether the company can sustain dividends and planned capital expenditures as earnings and cash generation decline.
- Developments in the pending lawsuits, potential uninsured exposure, and any change in management’s assessment of financial or earnings impact.
- Actual 2023 capital spending compared with the approximately $20 million estimate and the availability and cost of key raw materials.